Edgewise Therapeutics Inc (NASDAQ:EWTX) currently has a daily average trading volume of 1.81M but it saw 1247694 shares traded in last market. With a market cap of 1.53B USD, the company’s current market price of $14.57 came rising about 4.15 while comparing to the previous closing price of $13.99. In past 52 weeks, the stock remained buoying in the range of price level as high as $38.12 and as low as $10.60.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Guggenheim which initiated the stock as “Buy” in its note to investors issued on April 30, 2025, recommending a price target of $41 for it. Scotiabank downgraded its recommendation for the stock as a “Sector Perform” from “Sector Outperform” on April 02, 2025 while assigning a price target of $14. Scotiabank also issued its recommendations for the stock as it initiated the price target for the stock is $50.
Over the week, EWTX’s stock price is moving -0.14% down while it is -5.76% when we observe its performance for the past one month. Year-to-date it is -45.43% down and over the past year, the stock is showing a downside performance of -14.85%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.42 while estimate for next year EPS is -1.76.
Currently, Edgewise Therapeutics Inc’s total number of outstanding shares is 95.21M with 0.53% of that held by the insiders while 104.05% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -33.72% and return on equity (ROE) at -30.29%. Stock’s beta reads 0.29. Stock has a price to book (P/B) ratio of 3.23. Its return on asset (ROA) is -28.98% on average.
